How much funding has Merida Biosciences raised?

Merida Biosciences has raised $121.0M in total funding, most recently a Series A round.

When was Merida Biosciences founded?

Merida Biosciences was founded in 2024.

Where is Merida Biosciences headquartered?

Merida Biosciences is headquartered in Boston, United States.

What industry is Merida Biosciences in?

Merida Biosciences operates in Biotech, Healthcare.

Merida Biosciences

Q: Who are Merida Biosciences's investors?

Merida Biosciences's investors include Third Rock Ventures, Bain Capital Life Sciences, BVF Partners, GV, Perceptive Advisors.

Precision therapy for autoimmune-driven diseases is now within reach

Boston, United States · Founded 2024 · $121.0M raised

Biotech

Healthcare

Headquarters: Boston
Founded: 2024
Business Model: B2B
Website: meridabio.com

Total Funding: $121.0M
Last Round: $121.0M Series AApr 2025
Rounds: 1

About

Merida Biosciences is a precision immunology company developing therapeutics for autoimmune and allergic diseases. Its novel platform aims to target and eliminate the pathogenic drivers of antibody-driven diseases with unprecedented precision and durability, addressing the root cause of disease rather than the non-specific, side-effect-prone treatments available today. Founded by Dario Gutierrez, Ph.D. with backing from Third Rock Ventures, the company launched publicly in April 2025 with $121M in Series A financing.

Summary

Merida Biosciences is a Biotech company based in Boston, United States, founded in 2024. It has raised $121.0M in total across 1 round, most recently a $121.0M Series A round in Apr 2025. Investors include Third Rock Ventures, Bain Capital Life Sciences and BVF Partners.